These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2650124)

  • 1. Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
    Tanabe K; Toma H; Sagara R; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):293-5. PubMed ID: 2650124
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    Mangino MJ; Brunt EM; Von Doersten P; Anderson CB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection.
    Knoll T; Oltersdorf J; Göttmann U; Schaub M; Michel MS; Kirchengast M; van der Woude FJ; Rohmeiss P; Braun C
    Transpl Int; 2003 Jun; 16(6):425-9. PubMed ID: 12819874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151): a potent, specific thromboxane A2 synthetase inhibitor.
    Nishikawa K; Terashita Z; Imamoto T; Imura Y; Hirata M; Terao S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():523-5. PubMed ID: 2936160
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of prostaglandin I2 analogue and thromboxane A2 synthetase inhibitor on chronic rejection in rats.
    Hirano T; Nakafusa Y; Nishinaka H; Takeda K; Kawano R; Nakano M; Arima T; Motoyama K; Nakamura K; Torada N; Ikematsu H; Kamei T; Tanaka M
    Transplant Proc; 1997; 29(1-2):1520. PubMed ID: 9123408
    [No Abstract]   [Full Text] [Related]  

  • 6. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental models of chronic renal allograft rejection.
    Paul LC
    Transplant Proc; 1995 Jun; 27(3):2126-8. PubMed ID: 7792906
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigen-independent events mimic characteristic changes of chronic allograft rejection.
    Tullius SG; Heemann UW; Azuma H; Hancock WW; Pradham P; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):561-3. PubMed ID: 7879099
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
    Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonimmune factors may contribute to chronic rejection of kidney transplants.
    Azuma H; Tullius SG; Heemann UW; Tilney NL
    Transplant Proc; 1994 Aug; 26(4):2109-10. PubMed ID: 8066686
    [No Abstract]   [Full Text] [Related]  

  • 11. Angioscopic study of the antithrombotic effect of a new selective thromboxane A2 synthetase inhibitor, CV-4151, on experimental arterial thrombi.
    Matsubara T; Yamazoe M; Tamura Y; Igarashi Y; Izumi T; Shibata A
    Am Heart J; 1989 Oct; 118(4):837-9. PubMed ID: 2529751
    [No Abstract]   [Full Text] [Related]  

  • 12. The Fischer-Lewis model of chronic allograft rejection--a summary.
    Marco ML
    Nephrol Dial Transplant; 2006 Nov; 21(11):3082-6. PubMed ID: 16935901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts.
    Ruiz P; Coffman TM; Klotman PE; Sanfilippo F
    Transplantation; 1989 Oct; 48(4):660-6. PubMed ID: 2799920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
    Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A
    Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat.
    Paul LC; Chea R; Davidoff A; Benediktsson H
    Transplant Proc; 1994 Oct; 26(5):2567-8. PubMed ID: 7940793
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboxane synthesis inhibition and renal allograft function.
    Anderson C; Jendrisak M; Brunt E; Tobimatsu M; Murphy M; Sicard G; Mangino M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1161-4. PubMed ID: 2650085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of chronic kidney allograft rejection are reversible after retransplantation.
    Tullius SG; Heemann UW; Wagner K; Tilney NL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):906-7. PubMed ID: 8442264
    [No Abstract]   [Full Text] [Related]  

  • 18. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophils and macrophages are prominent in the pathophysiology of chronic rejection of rat kidney allografts.
    Heemann UW; Tullius SG; Schumann V; Tilney NL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):937-8. PubMed ID: 8442274
    [No Abstract]   [Full Text] [Related]  

  • 20. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.